The Journal of Immunology, Vol 151, Issue 1 377-388, Copyright © 1993 by American Association of Immunologists

ARTICLES

Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor

EL Morgan, JA Ember, SD Sanderson, W Scholz, R Buchner, RD Ye and TE Hugli
Department of Immunology, Scripps Research Institute, La Jolla, CA 92037.

Results obtained indicate that a site-directed polyclonal antibody specific for a synthetic peptide based on the predicted amino-terminal sequence of human C5aR (anti-C5aR(9-29)) is capable of binding to both normal human and transfected cells bearing C5aR. Flow cytometric analysis of stable murine L cell transfectants (C5aR-neo), human neutrophils, and human monocytes indicated that these cells bound anti- C5aR(9-29) in a specific manner. Moreover, F(ab')2 fragments of anti- C5aR(9-29) specifically neutralized proinflammatory and immunoregulatory activities induced by natural human C5a. This antiserum was found to block, in a dose-dependent manner, 1) zymosan- induced neutrophil chemotaxis, 2) C5a-induced enzyme release from neutrophils, and 3) C5a-induced cytokine production (IL-6 and IL-8) from human monocytes in vitro. These results suggest that this site- directed polyclonal antiserum specifically interacts with the human C5aR molecule. To the best of our knowledge, none of the existing reports in the literature provided evidence for a site-directed antiserum to C5aR that was capable of specifically blocking C5a- mediated inflammatory/immunoregulatory activities in vitro. Studies conducted with anti-C5aR(9-29) indicated that this antiserum effectively blocked C5a-mediated cell activation but by itself did not activate either neutrophils or monocytes. Combined, these data suggest that this antiserum does not interact with the C5a "effector" site but sterically interferes with C5a binding to its receptor by interacting with the extracellular amino-terminal region of the receptor.

This article has been cited by other articles:

				A. Gupta, F. M. Decaillot, I. Gomes, O. Tkalych, A. S. Heimann, E. S. Ferro, and L. A. Devi Conformation State-sensitive Antibodies to G-protein-coupled Receptors J. Biol. Chem., February 23, 2007; 282(8): 5116 - 5124. [Abstract] [Full Text] [PDF]

				A.-M. Scola, A. Higginbottom, L. J. Partridge, R. C. Reid, T. Woodruff, S. M. Taylor, D. P. Fairlie, and P. N. Monk The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding J. Biol. Chem., February 9, 2007; 282(6): 3664 - 3671. [Abstract] [Full Text] [PDF]

				S. M. Waters, R. M. Brodbeck, J. Steflik, J. Yu, C. Baltazar, A. E. Peck, D. Severance, L. Y. Zhang, K. Currie, B. L. Chenard, et al. Molecular Characterization of the Gerbil C5a Receptor and Identification of a Transmembrane Domain V Amino Acid That Is Crucial for Small Molecule Antagonist Interaction J. Biol. Chem., December 9, 2005; 280(49): 40617 - 40623. [Abstract] [Full Text] [PDF]

				H. Boshra, J. Li, R. Peters, J. Hansen, A. Matlapudi, and J. O. Sunyer Cloning, Expression, Cellular Distribution, and Role in Chemotaxis of a C5a Receptor in Rainbow Trout: The First Identification of a C5a Receptor in a Nonmammalian Species J. Immunol., April 1, 2004; 172(7): 4381 - 4390. [Abstract] [Full Text] [PDF]

				M. Otto, H. Hawlisch, P. N. Monk, M. Muller, A. Klos, C. L. Karp, and J. Kohl C5a Mutants Are Potent Antagonists of the C5a Receptor (CD88) and of C5L2: POSITION 69 IS THE LOCUS THAT DETERMINES AGONISM OR ANTAGONISM J. Biol. Chem., January 2, 2004; 279(1): 142 - 151. [Abstract] [Full Text] [PDF]

				A. A. Floreani, T. A. Wyatt, J. Stoner, S. D. Sanderson, E. G. Thompson, D. Allen-Gipson, and A. J. Heires Smoke and C5a Induce Airway Epithelial Intercellular Adhesion Molecule-1 and Cell Adhesion Am. J. Respir. Cell Mol. Biol., October 1, 2003; 29(4): 472 - 482. [Abstract] [Full Text] [PDF]

				J. M. Klco, T. B. Lassere, and T. J. Baranski C5a Receptor Oligomerization: I. DISULFIDE TRAPPING REVEALS OLIGOMERS AND POTENTIAL CONTACT SURFACES IN A G PROTEIN-COUPLED RECEPTOR J. Biol. Chem., September 12, 2003; 278(37): 35345 - 35353. [Abstract] [Full Text] [PDF]

				E. A. KALLIO, K. B. LEMSTRÖM, P. J. HÄYRY, U. S. RYAN, and P. K. KOSKINEN Blockade of Complement Inhibits Obliterative Bronchiolitis in Rat Tracheal Allografts Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1332 - 1339. [Abstract] [Full Text]

				T.-H. Chao, J. A. Ember, M. Wang, Y. Bayon, T. E. Hugli, and R. D. Ye Role of the Second Extracellular Loop of Human C3a Receptor in Agonist Binding and Receptor Function J. Biol. Chem., April 2, 1999; 274(14): 9721 - 9728. [Abstract] [Full Text] [PDF]

				G. Servant, O. D. Weiner, E. R. Neptune, J. W. Sedat, and H. R. Bourne Dynamics of a Chemoattractant Receptor in Living Neutrophils during Chemotaxis Mol. Biol. Cell, April 1, 1999; 10(4): 1163 - 1178. [Abstract] [Full Text]

				Y. Fukuoka, J. A. Ember, and T. E. Hugli Molecular Cloning of Two Isoforms of the Guinea Pig C3a Anaphylatoxin Receptor: Alternative Splicing in the Large Extracellular Loop J. Immunol., September 15, 1998; 161(6): 2977 - 2984. [Abstract] [Full Text] [PDF]

				T. C. Pellas, W. Boyar, J. van Oostrum, J. Wasvary, L. R. Fryer, G. Pastor, M. Sills, A. Braunwalder, D. R. Yarwood, R. Kramer, et al. Novel C5a Receptor Antagonists Regulate Neutrophil Functions In Vitro and In Vivo J. Immunol., June 1, 1998; 160(11): 5616 - 5621. [Abstract] [Full Text] [PDF]

				W. A. Wilmer, P. T. Kaumaya, J. A. Ember, and F. G. Cosio Receptors for the Anaphylatoxin C5a (CD88) on Human Mesangial Cells J. Immunol., June 1, 1998; 160(11): 5646 - 5652. [Abstract] [Full Text] [PDF]

				A. A. Floreani, A. J. Heires, L. A. Welniak, A. Miller-Lindholm, L. Clark-Pierce, S. I. Rennard, E. L. Morgan, and S. D. Sanderson Expression of Receptors for C5a Anaphylatoxin (CD88) on Human Bronchial Epithelial Cells: Enhancement of C5a-Mediated Release of IL-8 upon Exposure to Cigarette Smoke J. Immunol., May 15, 1998; 160(10): 5073 - 5081. [Abstract] [Full Text] [PDF]

				Z. Chen, X. Zhang, N. C. Gonnella, T. C. Pellas, W. C. Boyar, and F. Ni Residues 21-30 within the Extracellular N-terminal Region of the C5a Receptor Represent a Binding Domain for the C5a Anaphylatoxin J. Biol. Chem., April 24, 1998; 273(17): 10411 - 10419. [Abstract] [Full Text] [PDF]

				P. Gasque, S. K. Singhrao, J. W. Neal, P. Wang, S. Sayah, M. Fontaine, and B. P. Morgan The Receptor for Complement Anaphylatoxin C3a Is Expressed by Myeloid Cells and Nonmyeloid Cells in Inflamed Human Central Nervous System: Analysis in Multiple Sclerosis and Bacterial Meningitis J. Immunol., April 1, 1998; 160(7): 3543 - 3554. [Abstract] [Full Text] [PDF]

				P. N. Monk, M. D. Barker, L. J. Partridge, and J. E. Pease Mutation of Glutamate 199 of the Human C5a Receptor Defines a Binding Site for Ligand Distinct from the Receptor N Terminus J. Biol. Chem., July 14, 1995; 270(28): 16625 - 16629. [Abstract] [Full Text] [PDF]